AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11781675 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitosterol ester fortified spread (2.4 g)
Number of subjects: 37
Study 9476087 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.05 mg/day) and norethisterone acetate orally (2.5 mg/day) for 12 days every 2 months (group A)
Number of subjects: 172
Study 9476087 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.05 mg/day) and norethisterone acetate orally (2.5 mg/day) for 12 days every 3 months (group B)
Number of subjects: 172
Study 9476087 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 172
Study 7943861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autohemotransfusion
Number of subjects: 0
Study 3928264 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ketoprofen
Number of subjects: 60
Study 3928264 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g lysine acetylsalicylate
Number of subjects: 60
Study 3928264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30165472 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate intake of vitamin E
Number of subjects: 1002
Study 29555857 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (100 μg, p.o.)
Number of subjects: 24
Study 29555857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg, p.o.) + LSD (100 μg, p.o.)
Number of subjects: 24
Study 29555857 — intervention group
Group type: COMPARATOR
Intervention: Placebo + LSD (100 μg, p.o.)
Number of subjects: 24
Study 29555857 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Placebo
Number of subjects: 24
Study 27913408 — intervention group
Group type: EXPERIMENTAL
Intervention: d-serine administration
Number of subjects: 40
Study 27913408 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study 24346808 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg)
Number of subjects: 0
Study 24346808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (40 mg) plus Cinnarizine (25 mg)
Number of subjects: 0
Study 24346808 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclizine (25 mg)
Number of subjects: 0
Study 24346808 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg) plus D-Amphetamine (10 mg)
Number of subjects: 0
Study 24346808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23720216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy
Number of subjects: 399
Study 23720216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on pretreatment variables
Number of subjects: 399
Study 23720216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 399
Study 20500134 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound for 4 consecutive days
Number of subjects: 48
Study 20500134 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (amoxicillin) for a 10-day course
Number of subjects: 48
Study 20500134 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 48
Study 20500134 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (amoxicillin)
Number of subjects: 48
Study 18381313 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 60
Study 18381313 — intervention group
Group type: COMPARATOR
Intervention: Bone‐patellar tendon‐bone autograft
Number of subjects: 60
Study 18381313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 16618011 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 to 1700 mg daily)
Number of subjects: 40
Study 16618011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 14560412 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross-linked polyethylene (Crossfire; Stryker Howmedica Osteonics)
Number of subjects: 46
Study 14560412 — intervention group
Group type: COMPARATOR
Intervention: Standard polyethylene (N(2)/Vac, Stryker Howmedica Osteonics)
Number of subjects: 46
Study 10780766 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled flunisolide (500 microg b.i.d)
Number of subjects: 32
Study 10780766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8833892 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 8833892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1361250 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms)
Number of subjects: 8
Study 1361250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7004560 — intervention group
Group type: EXPERIMENTAL
Intervention: Single agent chlorambucil
Number of subjects: 47
Study 7004560 — intervention group
Group type: COMPARATOR
Intervention: Five-drug combination (chlorambucil, methotrexate, fluorouracil, vincristine, adriamycin)
Number of subjects: 47
Study 30730274 — intervention group
Group type: EXPERIMENTAL
Intervention: Birch pollen allergoid subcutaneous immunotherapy (4 weekly injections)
Number of subjects: 130
Study 30730274 — intervention group
Group type: EXPERIMENTAL
Intervention: Birch pollen allergoid subcutaneous immunotherapy (7 weekly injections)
Number of subjects: 130
Study 28073844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg intravenously every 2 weeks
Number of subjects: 418
Study 28073844 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine 1,000 mg/m2 intravenously every 3 weeks
Number of subjects: 418
Study 26060154 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (20 minutes, twice a day for four days)
Number of subjects: 40
Study 26060154 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 40
Study 26060154 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine therapy only)
Number of subjects: 40
Study 23371747 — intervention group
Group type: EXPERIMENTAL
Intervention: Group O (opposite change for eyes and hand)
Number of subjects: 40
Study 23371747 — intervention group
Group type: EXPERIMENTAL
Intervention: Group S (same change for eyes and hand)
Number of subjects: 40
Study 23371747 — intervention group
Group type: COMPARATOR
Intervention: Group E (eyes-only adaptation)
Number of subjects: 40
Study 23371747 — intervention group
Group type: COMPARATOR
Intervention: Group H (hand-only adaptation)
Number of subjects: 40
Study 23371747 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ON (no visual feedback of the hand)
Number of subjects: 40
Study 23371747 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adaptation
Number of subjects: 40
Study 21330484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 150
Study 21330484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study 20037100 — intervention group
Group type: EXPERIMENTAL
Intervention: pi-circuit technique (off-pump coronary artery bypass, aorta no-touch technique)
Number of subjects: 200
Study 17551378 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment consisting of scaling/root planing and oral hygiene instruction
Number of subjects: 29
Study 17551378 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 29
Study 17551378 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 29
Study 17142410 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.5% bupivacaine into the iliac crest harvest site
Number of subjects: 60
Study 17142410 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study 17142410 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received morphine sulfate via patient-controlled analgesia pump
Number of subjects: 60
Study 14512038 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements (352 kcal/day)
Number of subjects: 109
Study 14512038 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital nutrition
Number of subjects: 109
Study 10658936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (8 mg/kg)
Number of subjects: 10
Study 10658936 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA; 3 mg/kg) after CsA
Number of subjects: 10
Study 10658936 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA)
Number of subjects: 10
Study 10658936 — intervention group
Group type: COMPARATOR
Intervention: Control day (without CsA)
Number of subjects: 10
Study 10658936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (8 mg/kg) followed by L-NMMA
Number of subjects: 10
Study 7551612 — intervention group
Group type: COMPARATOR
Intervention: Daily live self-exposure and ritual prevention to external cues (Ex)
Number of subjects: 46
Study 7551612 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily self-exposure to imagined internal cues of the consequences of not ritualising (Exi)
Number of subjects: 46
Study 2042792 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine
Number of subjects: 65
Study 2042792 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nicardipine
Number of subjects: 65
Study 2042792 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 65
Study 7233310 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Health Project (FHP) group
Number of subjects: 2
Study 7233310 — intervention group
Group type: COMPARATOR
Intervention: Community Care (CC) group
Number of subjects: 2
Study 29978261 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 46
Study 29978261 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 46
Study 26976971 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (oral fluoropyrimidine)
Number of subjects: 795
Study 25572482 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz, 110% MT, 420 stimuli/day
Number of subjects: 33
Study 25572482 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz, 110% MT, 900 stimuli/day
Number of subjects: 33
Study 25572482 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz, 80% MT, 750 stimuli/day
Number of subjects: 33
Study 23244367 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma writing intervention (4 sessions of 30 minutes each)
Number of subjects: 244
Study 23244367 — intervention group
Group type: COMPARATOR
Intervention: Daily events writing (attention control)
Number of subjects: 244
Study 20940567 — intervention group
Group type: EXPERIMENTAL
Intervention: PSP clinical pathway applied to treatment group (n = 30)
Number of subjects: 60
Study 18060441 — intervention group
Group type: EXPERIMENTAL
Intervention: ramelteon 16 mg
Number of subjects: 26
Study 18060441 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study 15929507 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on the critical appraisal of published research papers and practice guidelines (Strategy A)
Number of subjects: 1470
Study 15929507 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on the critical appraisal of published research papers and practice guidelines plus training on management of change in clinical practice (Strategy B)
Number of subjects: 1470
Study 15929507 — intervention group
Group type: COMPARATOR
Intervention: Strategy A
Number of subjects: 1470
Study 15929507 — intervention group
Group type: COMPARATOR
Intervention: Strategy B
Number of subjects: 1470
Study 12912787 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived time constraints
Number of subjects: 201
Study 12912787 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived support for physical activity
Number of subjects: 201
Study 12912787 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-worth scale
Number of subjects: 201
Study 10587552 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal Replacement Therapy (HRT) - conjugated oestrogen 0.625 mg daily from day 1 to day 21 plus medroxyprogesterone acetate 5 mg daily days 10-21
Number of subjects: 28
Study 10587552 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol - 0.5 microg daily
Number of subjects: 28
Study 10587552 — intervention group
Group type: COMPARATOR
Intervention: Comparison of HRT and Calcitriol
Number of subjects: 28
Study 8600863 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 112
Study 8600863 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 112
Study 1938979 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline 75 mg, 1 tablet
Number of subjects: 1141
Study 1938979 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline 75 mg, 1/2 tablet
Number of subjects: 1141
Study 1938979 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 1 tablet
Number of subjects: 1141
Study 1938979 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 1/2 tablet
Number of subjects: 1141
Study 7148967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal resting hand splints
Number of subjects: 10
Study 7148967 — intervention group
Group type: COMPARATOR
Intervention: Volar resting hand splints
Number of subjects: 10
Study 7148967 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (both groups)
Number of subjects: 10
Study 7148967 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects (both groups)
Number of subjects: 10
Study 30830179 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 657
Study 30830179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 657
Study 28067086 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 2000 mg of amoxicillin clavulanate, continued with amoxicillin clavulanate postoperatively
Number of subjects: 71
Study 28067086 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 600 mg of clindamycin, continued with clindamycin postoperatively
Number of subjects: 71
Study 28067086 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic chlorhexidin rinsing, continued randomized amoxicillin clavulanate or clindamycin postoperatively
Number of subjects: 71
Study 28067086 — intervention group
Group type: COMPARATOR
Intervention: Control group with clindamycin postoperatively
Number of subjects: 71
Study 25725179 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low-dose methylprednisolone infusion (1mg/kg loading dose followed by 2mg/Kg/24 hours for 1 day)
Number of subjects: 72
Study 25725179 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose methylprednisolone (15 mg/kg before cardiopulmonary bypass)
Number of subjects: 72
Study 25725179 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low-dose methylprednisolone infusion
Number of subjects: 72
Study 25725179 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose methylprednisolone
Number of subjects: 72
Study 23911008 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice training exercises and vocal hygiene education (5 sessions total, including 4 vocal exercise sessions)
Number of subjects: 102
Study 23911008 — intervention group
Group type: COMPARATOR
Intervention: Control group with vocal hygiene education (2 sessions)
Number of subjects: 102
Study 21220404 — intervention group
Group type: EXPERIMENTAL
Intervention: High optimism quartile
Number of subjects: 5634
Study 21220404 — intervention group
Group type: COMPARATOR
Intervention: Lowest optimism category
Number of subjects: 5634
Study 19190213 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone (CD)
Number of subjects: 264
Study 19190213 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine plus Chloroquine (SP + CQ)
Number of subjects: 264
Study 17728962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (RAZA Pharmaniaga, Malaysia)
Number of subjects: 24
Study 17728962 — intervention group
Group type: COMPARATOR
Intervention: Ciprobay (Bayer AG, Germany)
Number of subjects: 24
Study 15142155 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine‐prilocaine solution
Number of subjects: 42
Study 15142155 — intervention group
Group type: COMPARATOR
Intervention: inert cream
Number of subjects: 42
Study 11300448 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg oral estradiol for three months
Number of subjects: 19
Study 11300448 — intervention group
Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 19
Study 9339168 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 74
Study 9339168 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 74
Study 8288374 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pin placement between the anterior iliac spines
Number of subjects: 0
Study 8288374 — intervention group
Group type: COMPARATOR
Intervention: Conventional pin placement at the superior iliac crest
Number of subjects: 0
Study 3524548 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 0
Study 3524548 — intervention group
Group type: COMPARATOR
Intervention: Intravenous diazoxide
Number of subjects: 0
Study 30396557 — intervention group
Group type: EXPERIMENTAL
Intervention: Etonogestrel (ENG) implant
Number of subjects: 103
Study 30396557 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 103
Study 26740682 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-micronutrient supplement (MMN) providing 18 micronutrients including 800 μg retinol equivalents of vitamin A
Number of subjects: 1320
Study 26740682 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) with the same nutrients as MMN plus 4 minerals and macronutrients
Number of subjects: 1320
Study 26740682 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (control group) during pregnancy and placebo (calcium tablet) during the first 6 months postpartum
Number of subjects: 1320
Study 24158593 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosdevirine 100 mg
Number of subjects: 35
Study 24158593 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosdevirine 200 mg
Number of subjects: 35
Study 24158593 — intervention group
Group type: COMPARATOR
Intervention: Control (Etravirine 200 mg twice daily)
Number of subjects: 35
Study 23082409 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral program
Number of subjects: 540
Study 23082409 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 540
Study 19195912 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin therapy
Number of subjects: 30
Study 18487271 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent information recall
Number of subjects: 82
Study 16162986 — intervention group
Group type: EXPERIMENTAL
Intervention: WIPSS Brain‐Pad mouth guard
Number of subjects: 646
Study 16162986 — intervention group
Group type: COMPARATOR
Intervention: Standard use mouth guard of choice
Number of subjects: 646
Study 14700098 — intervention group
Group type: EXPERIMENTAL
Intervention: BSS with antibiotics (vancomycin and gentamycin)
Number of subjects: 640
Study 14700098 — intervention group
Group type: COMPARATOR
Intervention: BSS-only
Number of subjects: 640
Study 11568134 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 15
Study 11568134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9368818 — intervention group
Group type: EXPERIMENTAL
Intervention: Learner centred group
Number of subjects: 66
Study 9368818 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert group
Number of subjects: 66
Study 9368818 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 1555950 — intervention group
Group type: COMPARATOR
Intervention: External beam irradiation to a dose of 2000 cGy delivered in 10 fractions over 2 weeks (Group A)
Number of subjects: 50
Study 1555950 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose rate intracavitary irradiation to a dose of 1200 cGy delivered in two sessions of 600 cGy each a week apart (Group B)
Number of subjects: 50
Study 3927960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (5 mg h-1 for 3 h)
Number of subjects: 6
Study 3927960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30614860 — intervention group
Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0
Study 30614860 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch pacing (LBBP)
Number of subjects: 0
Study 27306581 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg/d
Number of subjects: 62
Study 27306581 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 50 mg/d
Number of subjects: 62
Study 26421929 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing-based psychoeducational group intervention
Number of subjects: 117
Study 26421929 — intervention group
Group type: COMPARATOR
Intervention: Conventional postsurgical visits
Number of subjects: 117
Study 23522992 — intervention group
Group type: EXPERIMENTAL
Intervention: Asmofilcon A lens
Number of subjects: 47
Study 23522992 — intervention group
Group type: COMPARATOR
Intervention: Lotrafilcon B lens
Number of subjects: 47
Study 23522992 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lenses
Number of subjects: 47
Study 21670942 — intervention group
Group type: EXPERIMENTAL
Intervention: Friskis&Svettis® Open Doors programme (60-minute comprehensive group-training programme, twice a week for 14 weeks)
Number of subjects: 35
Study 21670942 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 35
Study 19734595 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg from POD0 to POD5 and 200 mg until POD14 plus IV PCA (fentanyl 1.0 mg/100 mL) postoperatively
Number of subjects: 60
Study 19734595 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus IV PCA postoperatively
Number of subjects: 60
Study 16724990 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI alternating with systemic chemotherapy (HA + SC group)
Number of subjects: 29
Study 16724990 — intervention group
Group type: COMPARATOR
Intervention: HR + SC group (control)
Number of subjects: 29
Study 15541082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (ASC)
Number of subjects: 19